REFERENCES
- Barrett A. M., Carter J., Fitzgerald J. D. Br. J. Pharmacol 1973; 48: 340
- Harry J. D., Knapp M. F., Linden R. J. Br. J. Pharmacol 1974; 51: 169
- Majid P. A., Vander Vijgh W. J. F., De Feijter P. J., Wardeh R., Van der Wall E. E., Ross J. P. Eur. J. Cardiol 1979; 9: 419
- Frishman W. H. N. Eng. J. Med. 1982; 306: 1456
- Buhring K. U., Garbe A. J. Chromatogr 1986; 382: 215
- Weiner D. L. Statistics in the Pharmaceutical Industry, C. R. Buncher, J. Y. Tsay. Marcel Dekker, New York 1981; 205
- Gibaldi M., Perrier D. Pharmacokinetics. 2nd ed., Marcel Dekker, New York 1982; 145
- Wagner J. G. Fundamentals of Clinical Pharmacokinetics. 1st ed., Drug Intelligence Publication, Hamilton, IL 1975; 285
- Grahnen A. Pharm. Int. 1984; 5: 100
- Westlake W. J. Biopharmaceutical Statistics for Drug Development, K. E. Peace. Marcel Dekker, New York 1988; 329
- Wolf-Coporda A., Plavsic F., Vrhovac B. Int. J. Clin. Pharmacol. Ther. Toxicol 1987; 25: 567
- U.S. Pharmacopoeial Convention, USP DI. Drug Information for the Health Care Professional. 14th ed., Author, Rockville, MD 1994; 550
- U.S. Pharmacopoeial Convention. The United States Pharmacopoeia XXIII. Author, Rockville, MD 1995
- Diletti E., Haushcke D., Steinijans V. W. Int. J. Clin. Pharmacol. Ther. Toxicol 1991; 29: 1
- Fitzgerald J. D., Ruffin R., Smedstad K. G., Roberts R., McAinsh J. 1978; 13: 81